Chemotherapy Drug Handling SWMS
Cytotoxic drug preparation and administration — Class II Type B biological safety cabinet operation, closed-system transfer device use, spill-response kit deployment, linen and sharps segregation, pregnant-worker reassignment protocol.
SWMS variants reference your state’s WHS legislation. Instant download after payment.
Cytotoxic drug preparation and administration in oncology pharmacies and clinical wards involves Class II BSC compounding, CSTD use, spill response, and segregated waste streams. WHS Regulation 2025 Part 7.1 classifies cytotoxics as hazardous chemicals with reproductive and carcinogenic toxicity, mandating documented controls and a SWMS for safe handling.
Hazards identified
3 hazards covered, sorted by priority.
Carcinogenic, mutagenic, reproductive toxicity to staff
Cytotoxic absorption plus bloodborne infection risk
Dermal absorption and secondary contamination of staff
Control measures
Hierarchy-of-controls order: elimination → substitution → isolation → engineering → administrative → PPE.
- 1Compound all cytotoxics in Class II Type B BSC compliant with AS/NZS 2567, certified annually.
- 2Use closed-system transfer devices and double-glove with cytotoxic-rated nitrile per SHPA guidelines.
- 3Reassign pregnant, breastfeeding or conceiving workers from cytotoxic duties on written request.
Applicable Codes of Practice
Hazardous chemical risk control, register, and health monitoring
BSC design, certification and operational testing requirements
High-Risk Construction Work triggered
Cytotoxic drugs are Schedule classified hazardous chemicals with carcinogenic and reproductive toxicity hazards.
SWMS mandatory before work; PCBU penalties up to $30,000 individual.
What you receive
- ✓Editable DOCX SWMS template
- ✓State-specific WHS legislation schedule
- ✓Cytotoxic hazard register
- ✓Worker sign-on register
Related legislation
- Work Health and Safety Act 2011
- WHS Regulation 2025 Chapter 7
- SHPA Standards for Chemotherapy Handling